S&P Keeps Buy on Teva Pharmaceutical

Ivax gets downgraded on merger deal with Teva, plus analysts' opinions on BellSouth, Whirlpool, and more

Teva Pharmaceutical (TEVA ): Reiterates 4 STARS (buy)

To continue reading this article you must be a Bloomberg Professional Service Subscriber.